What is Alterity Therapeutics Limited?
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 112.39M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.